..tpm diclo launch in the new year!
Themis Medicare, which is a partner firm of Australian drug delivery technology company Phosphagenics, entered into a license and supply agreement with Novartis India to sell its Themis diclofenac topical gel formulated using a unique TPM transdermal drug delivery system. The drug delivery system is available only with Themis in India. The information was revealed by Themis Medicare in a release to the Bombay Stock Exchange (BSE) post market on Friday, April 12, 2013.
Phosphagenics welcomed the exciting commercial expansion and said that endorsement by Novartis India is a significant validation its TPM technology by a global pharmaceutical company. - See more at: http://www.biospectrumasia.com/biospectrum/news/187024/novartis-sell-themis-diclofenac-topical-gel#.UmxEW-q4Yps
- Forums
- ASX - By Stock
- AVE
- novartis and poh ease the pain
novartis and poh ease the pain
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $200 | 80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
47 | 89568918 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 76234411 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
47 | 89568918 | 0.002 |
16 | 75995009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 76234411 | 24 |
0.004 | 17020712 | 17 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 11.26am 09/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |